MedPath
NMPA Approval

Elranatamab Injection

国药准字SJ20250010

March 4, 2025

Drug Information

埃纳妥单抗注射液

易瑞欧

注射剂

44mg(1.1mL)/瓶

生物制品

March 4, 2025

March 3, 2030

Company Information

Applicant Company

PFIZER INC.

66 Hudson Boulevard East, New York, NY 10001 United States of America

Manufacturing Company

7000 Portage Road, Kalamazoo, MI 49001, USA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

埃纳妥单抗注射液 - NMPA 批准文号 | MedPath